BCL2 and cervical cancer: Specifically, the genes ABL1, BAX, FASN, and PLAU exhibited abnormally high expression levels in cervical cancer specimens, in stark contrast to BCL2, IGF1, and NTRK3, which were markedly under-expressed (Figure 8A).